Biotech Company Says MRNA Detection Patent Should Be Canceled

(September 26, 2023, 11:54 AM EDT) -- ALEXANDRIA, Va. — The maker of the molecular profiling “Visium” system says in a Sept. 25 petition for inter partes review (IPR) that a patent directed to the spatial detection of oligonucleotides, such as mRNAs, in samples of tissue by using spatially barcoded arrays was anticipated by prior art....

Attached Documents

Related Sections